| pubmed-article:6219834 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6219834 | lifeskim:mentions | umls-concept:C0024141 | lld:lifeskim |
| pubmed-article:6219834 | lifeskim:mentions | umls-concept:C0023473 | lld:lifeskim |
| pubmed-article:6219834 | lifeskim:mentions | umls-concept:C0039195 | lld:lifeskim |
| pubmed-article:6219834 | lifeskim:mentions | umls-concept:C0175668 | lld:lifeskim |
| pubmed-article:6219834 | lifeskim:mentions | umls-concept:C1552913 | lld:lifeskim |
| pubmed-article:6219834 | lifeskim:mentions | umls-concept:C0079411 | lld:lifeskim |
| pubmed-article:6219834 | lifeskim:mentions | umls-concept:C0024284 | lld:lifeskim |
| pubmed-article:6219834 | lifeskim:mentions | umls-concept:C0050156 | lld:lifeskim |
| pubmed-article:6219834 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:6219834 | pubmed:dateCreated | 1983-5-5 | lld:pubmed |
| pubmed-article:6219834 | pubmed:abstractText | Complement-dependent lymphocytotoxic autoantibodies (CLA) are invariably present in sera of patients with active systemic lupus erythematosus (SLE). This study aimed to test for the influence of such antibodies on the in vitro generation of human alloantigen reactive proliferative and cytotoxic T cell responses. Unsensitized or alloantigen primed memory cells were pre-treated with CLA in the presence or absence of complement. Following stimulation of the remaining cells with allogeneic peripheral blood mononuclears, the proliferative and cytotoxic capacity was evaluated. Results indicated that only pre-treatment with CLA and complement influenced these reactions whereas in the absence of complement antibodies were totally ineffective. Pre-treatment of unsensitized precursor cells reduced and delayed both proliferative and cytotoxic reactivity; in contrast, pre-treatment of memory cells exclusively reduced cellular cytotoxicity. It thus appears that such SLE associated autoantibodies in the presence of complement are capable of modifying the balance between different subsets of alloreactive T cells. | lld:pubmed |
| pubmed-article:6219834 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6219834 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6219834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6219834 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6219834 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:6219834 | pubmed:issn | 0009-9104 | lld:pubmed |
| pubmed-article:6219834 | pubmed:author | pubmed-author:PfisterRR | lld:pubmed |
| pubmed-article:6219834 | pubmed:author | pubmed-author:StinglGG | lld:pubmed |
| pubmed-article:6219834 | pubmed:author | pubmed-author:HuberCC | lld:pubmed |
| pubmed-article:6219834 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6219834 | pubmed:volume | 50 | lld:pubmed |
| pubmed-article:6219834 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6219834 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6219834 | pubmed:pagination | 525-33 | lld:pubmed |
| pubmed-article:6219834 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:6219834 | pubmed:meshHeading | pubmed-meshheading:6219834-... | lld:pubmed |
| pubmed-article:6219834 | pubmed:meshHeading | pubmed-meshheading:6219834-... | lld:pubmed |
| pubmed-article:6219834 | pubmed:meshHeading | pubmed-meshheading:6219834-... | lld:pubmed |
| pubmed-article:6219834 | pubmed:meshHeading | pubmed-meshheading:6219834-... | lld:pubmed |
| pubmed-article:6219834 | pubmed:meshHeading | pubmed-meshheading:6219834-... | lld:pubmed |
| pubmed-article:6219834 | pubmed:meshHeading | pubmed-meshheading:6219834-... | lld:pubmed |
| pubmed-article:6219834 | pubmed:meshHeading | pubmed-meshheading:6219834-... | lld:pubmed |
| pubmed-article:6219834 | pubmed:meshHeading | pubmed-meshheading:6219834-... | lld:pubmed |
| pubmed-article:6219834 | pubmed:meshHeading | pubmed-meshheading:6219834-... | lld:pubmed |
| pubmed-article:6219834 | pubmed:meshHeading | pubmed-meshheading:6219834-... | lld:pubmed |
| pubmed-article:6219834 | pubmed:meshHeading | pubmed-meshheading:6219834-... | lld:pubmed |
| pubmed-article:6219834 | pubmed:year | 1982 | lld:pubmed |
| pubmed-article:6219834 | pubmed:articleTitle | Complement-dependent lymphocytotoxic antibodies (CLA) in systemic lupus erythematosus preferentially inhibit the generation of alloreactive cytotoxic T cells in secondary CML. | lld:pubmed |
| pubmed-article:6219834 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6219834 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6219834 | lld:pubmed |
